Search Browse Earnings

Monopar Therapeutics — SlamSEC

Monopar Therapeutics

Nasdaq:MNPR

Pharmaceutical Preparations·WILMETTE, IL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

FY 2024

Adj. EBITDA

—

Net Income

-$8.4M

FY 2024

EPS (Diluted)

-$3.04

FY 2024

Stock Price

$57.00

-2.6%

2026-03-11

52W Range

$26.05 – $105.00

P/E Ratio

-18.8x

Market Cap

$380.9M

Cash

$7.3M

FY 2024

Total Debt

—

Net Cash

$7.3M

FY 2024

Enterprise Value

$373.6M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—

CEO

Robinson Chandler

CFO

Vu Quan Anh